UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. __ )*
OXBORO MEDICAL INTERNATIONAL, INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
691384101
(CUSIP Number)
Mr. Kenneth Brimmer
720 South Fifth Street
Hopkins, MN 55343
Telephone: (612) 945-5402
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
December 8, 1997
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies
are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
- --------------------- -----------------------------
CUSIP NO. 691384101 13D
- --------------------- -----------------------------
- -------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
KENNETH BRIMMER
SSN: (NOT REQUIRED PER "SPECIAL INSTRUCTIONS")
- -------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [X]
- -------------------------------------------------------------------------------
SEC USE ONLY
3
- --------------------------------------------------------------------------------
SOURCE OF FUNDS
4
00 (CASH RESERVES)
- --------------------------------------------------------------------------------
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
5 YES [__]
NO [X]
- --------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
U.S.A.
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH
REPORTING PERSON WITH:
SOLE VOTING POWER 60,000
7
- -------------------------------------------------------------------------------<PAGE>
SHARED VOTING POWER 20,000
8
- --------------------------------------------------------------------------------
SOLE DISPOSITIVE POWER 60,000
9
- -------------------------------------------------------------------------------
SHARED DISPOSITIVE POWER 20,000
10
- --------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY
11 EACH REPORTING PERSON
80,000
- --------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW
12 (11) EXCLUDES CERTAIN SHARES (See instructions)
[X]
- --------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT
13 IN ROW (11)
ASSUMING 2,662,078 SHARES OUTSTANDING
AS OF THE DATE HEREOF, AMOUNT IN
ROW 11 REPRESENTS 3.01%
- --------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (See instructions)
14
IN AND OO (IRA ACCOUNT)
- -------------------------------------------------------------------------------
CUSIP NUMBER 691384101
Item 1. SECURITY AND ISSUER
(a) Title of Class of Securities: Common Stock
(b) Name of Issuer: Oxboro Medical International, Inc.
(c) Address of Issuer's Principal Executive Offices:
13828 Lincoln Street, N.E.
Ham Lake, MN 55304
Item 2. IDENTITY AND BACKGROUND
(a) Name of Person Filing: Kenneth Brimmer
(This Schedule 13d also pertains to shares owned by Jaye M. Snyder,
spouse of Kenneth Brimmer, and such shares are included within the
references herein.)
(b) Business Address:
720 South Fifth Street
Hopkins, MN 55343
(c) Principal Occupation or Employment: Business Manager
(d) Conviction in a criminal proceeding during the last five years: NO
(e) Subject, during the last five years, to a judgment, decree or final
order enjoining securities laws violations: NO
(f) Citizenship: Mr. Brimmer is a citizen of the United States.
Item 3. Source and Amount of Funds or Other Consideration: Cash reserves
Item 4. Purpose of Transaction
(a) The purpose of the acquisition of securities is for investment.
(b) The person filing this statement has no plans or proposals, at this
time, which would result in any of the transactions listed in Item
4(b) through 4(j), except that such person may, if market and
investment conditions appear appropriate and favorable, acquire
additional securities of the Issuer, for investment purposes only.
Item 5. Interest in Securities of the Issuer
(a) Number and Percentage of Class beneficially owned:
80,000 shares may be deemed beneficially owned within the meaning of
Rule 13d-3 of the Securities Exchange Act of 1934 by Kenneth
Brimmer and this represents 3.01% of the 2,662,078 shares shown as
outstanding in the Issuer's last Exchange Act filing, its Form
10-QSB, dated August 14, 1997.
In addition, under Section 13d-3(b), under some interpretations, the
reporting person may be viewed as the beneficial owner of 101,175
shares of the Issuer's Common Stock in which CMM Properties, LLC
(which also has reported its beneficial ownership on Schedule
13(d)) has a beneficial interest. If combined, such 101,175
shares and 80,000 shares, would represent 6.81% of the 2,662,078
shares assumed to be outstanding. See Item 6 below.
DISCLAIMER: Pursuant to Rule 13d-3, the Reporting Person disclaims any
interest of any kind, whether beneficial or otherwise, in the shares
of the Issuer owned beneficially by the person named above.
(b) For information on voting and dispositive power with respect to the
above listed shares, see Items 5-8 of the Cover Page.
(c) Recent transactions in Common Stock:
No. of Price or Range Nature of
Date or Period Shares of Prices Transaction
------------------ -------- --------------- --------------
9/23/97 to 12/3/97 30,000 $1.0195 to $1.27 Open Market
Purchase
11/24/97 50,000 $1.06250 Private Purchase
(d) Ability to Direct the Receipt of Dividends or the Proceeds of Sale of
Securities:
Not applicable.
(e) Last Date on Which Reporting Person Ceased to be a 5% Holder:
Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
There are no contracts, arrangements, understandings or relationships
(legal or otherwise) among the persons named in Item 2 and between
such persons and any person with respect to any securities of the
Issuer, except that Reporting Person has an informal, unwritten,
non-binding understanding with Gary Copperud, CMM Properties, LLC,
(who is mentioned in Item 5 above and who also is filing a Schedule
13(d)). Such understanding, to date, is to the effect that
each will try (but not necessarily beforehand) to keep the other
informed of any significant purchases or sales which such person
makes, and that each will share, with the other, information
concerning the Issuer, and requests for information addressed to
the Issuer, which might affect the valuation of their respective
investments.
Item 7. Material to be Filed as Exhibits
None
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATE: December 16, 1997
/S/ KENNETH BRIMMER
Kenneth Brimmer
